The CEO of 2019’s biggest biotech IPO told us how he’s upending the ‘same old corporate approach’ in healthcare with a stripped down and cost-conscious model
The biotech BridgeBio just made its stock market debut, marking the biggest biotech IPO of the year so far, according to Renaissance Capital's IPO Pro data platform. Shares of the genetic disease-focused company surged 62% in Thursday trading, giving the c…
bubmagJune 28, 2019